LabCorp CRU, Inc.

Daytona Beach, Florida 32117

0 studies enrolling now · 12 studies all time

What they study most

Healthy, Obese, Obesity, Overweight

Studies at this site

• A Multiple Dose Study of LY3502970 in Healthy Overweight and Obese Participants — Completed
• A Study of LY3484356 in Healthy Female Participants — Completed
• A Study of Imlunestrant (LY3484356) in Healthy Women — Completed
• A Bioequivalence Study of Mirikizumab (LY3074828) Solution in Healthy Participants — Completed
• A Study Comparing Two Formulations of Selpercatinib (LY3527723) in Healthy Participants — Completed
• A Relative Bioavailability Study of Selpercatinib (LY3527723) in Healthy Participants — Completed
• A Study to Compare Two Formulations of Mirikizumab (LY3074828) in Healthy Participants — Completed
• A Study of Lebrikizumab (LY3650150) Administered by Two Different Devices in Healthy Participants — Completed
• A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants — Completed
• A Single-Dose Study of LY3471851 in Healthy Participants — Completed
• A Study of LY3457263 in Obese Participants — Completed
• Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants — Stopped early